Real-World Data on the Efficacy and Safety of Fexuprazan in Patients with Gastroesophageal Reflux Disease: Interim Analysis of Post-Marketing Surveillance. (PubMed, Gut Liver) - Jun 11, 2026 - "Fexuprazan demonstrated consistent efficacy with a favorable safety profile in the real-world management of GERD, including in older patients. These interim results support the use of fexuprazan as a safe and effective treatment option, including in older patients."
Journal • P4 data • Real-world evidence • Gastroenterology • Gastroesophageal Reflux Disease
|
|
Areum Lee; Hye Won Lee; Hyeong Cheol Jeong; Jae J Kim; Jae Won Seo; Jaehong Chun; Jeong Hyeon Cho; Jie-Hyun Kim; Ki Hong Lee; Kyung Oh Kim; Moo In Park; Seung Ho Choi; Si Hyung Lee; Woo Seok Lee; Yongmin Jo
|